Skip to main content
. 2012 Jun 20;7(6):e38557. doi: 10.1371/journal.pone.0038557

Figure 2. Sensitivity of the ICER to the cost of cetuximab per mg and the risk of progression in the cetuximab based strategy.

Figure 2